Results 121 to 130 of about 35,844 (248)

Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management

Journal of Neuroendocrinology, Volume 38, Issue 1, January 2026.
Abstract Bone metastases (BMs) were reported in <15% of cases of neuroendocrine neoplasms (NENs). Their clinical behavior is various and clinical management is still undefined. This study aimed to describe the clinical practical management and survival outcome of neuroendocrine neoplasm patients with BMs.
Nicola Fazio, Patrick Maisonneuve, Anna Maria Frezza, Nicoletta Ranallo, Toni Ibrahim, Anna La Salvia, Maria Pia Brizzi, Chiara De Divitiis, Salvatore Tafuto, Sara Pusceddu, Riccardo Marconcini, Mauro Cives, Cristina Ferrari, Davide Campana, Delia De Lisi, Daniele Santini, Antongiulio Faggiano, Roberta Modica, Sara Massironi, Antonio Bianchi, Francesco Panzuto, Lorenzo Antonuzzo, Elisa Pellegrini, Vito Amoroso, Ivana Puliafito, Elettra Merola, Nicola Silvestris, Chiara Maria Grana, Francesca Spada   +28 more
wiley   +1 more source

A rare case of sphenoid giant cell tumor: Case report & review of imaging features post short-term denosumab treatment

, 2022
Farid Aassouani, Nizar El Bouardi, Yahya Charifi, Kaoutar Maadin, Amina Bouziane, Meryem Halοua, Moulay Youssef Alaoui Lamrani, Samia Arifi, Touria Bouhafa, Meriem Boubbou, Mustapha Maâroufi, Badreeddine Alami   +11 more
openalex   +1 more source

Bilateral Orocutaneous Fistulas and Mandibular Osteonecrosis

International Journal of Dermatology, Volume 65, Issue 2, Page 374-375, February 2026.
Krisztian Nemeth, Mollye Goldberg, Zachary Fridirici   +2 more
wiley   +1 more source

Severe Hypercalcemia and Confusion in a Middle‐Aged Male: The Hidden Diagnosis of Parathyroid Carcinoma

Case Reports in Endocrinology, Volume 2026, Issue 1, 2026.
Parathyroid cancer (PC) is one of the rarest causes of primary hyperparathyroidism (PHPT), typically exhibiting an indolent course but presenting with more severe symptoms compared to its benign counterparts. The diagnosis is most often made postoperatively through histopathological examination; however, certain clinical and biochemical features may ...
Helena Fahmi, Mahmoud Karaki, Fatima Yasmin, Layal Akl, Paola Atallah, Osamu Isozaki   +5 more
wiley   +1 more source

Adrenal Crisis Induced by Zoledronic Acid in Two Patients With Hypopituitarism: A Case Report and Literature Review

Case Reports in Endocrinology, Volume 2026, Issue 1, 2026.
Adrenal insufficiency (AI) is characterized by inadequate steroid hormone production and is frequently a consequence of hypopituitarism, which is also associated with increased risk of osteoporosis due to deficiencies in growth hormone, gonadotropins, and other pituitary hormones.
Abrar Mohammed AlFaifi, Wael Mohammad AlMistehi, Osamu Isozaki   +2 more
wiley   +1 more source

Effect of denosumab on the incidence of fractures and mortality in patients undergoing hemodialysis: A retrospective cohort study.

PLoS ONE
BackgroundPatients undergoing hemodialysis are at an elevated risk of fractures; however, substantial evidence for osteoporosis treatment in this population is lacking.
Arisa Kobayashi, Tatsuhiro Yaginuma, Kazuhiko Kato, Akio Nakashima, Ichiro Ohkido, Takashi Yokoo   +5 more
doaj   +1 more source

Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study [PDF]

, 2021
Chiara Marocco, Giovanna Zimatore, Edoardo Mocini, Rachele Fornari, Giovanni Iolascon, Maria Chiara Gallotta, Viviana Maria Bimonte, Carlo Baldari, Andrea Lenzi, Silvia Migliaccio   +9 more
openalex   +1 more source

The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong [PDF]

, 2013
published_or_final_versio
Cheung, SKW, Cheung, TC, Choi, PTF, Chow, SLE, Ho, HYA, Ip, TP, Kan, SYA, Kung, WCA, Lee, KK, Leung, KLF, Leung, YYJ, Lo, STS, Sy, CT, Wong, YW   +13 more
core  

297 ADHERENCE TO DENOSUMAB PRESCRIPTION FOLLOWING DISCHARGE FROM A GERIATRIC REHABILITATION UNIT [PDF]

, 2022
A Lynch, D Murray, O Whelan, Sarah Mello
openalex   +1 more source

Denosumab Treatment of Severe Disuse Osteoporosis in a Boy With Spinal Muscular Atrophy

Acta Medica Iranica, 2017
Denosumab is a fully human recombinant monoclonal antibody to the receptor activator of nuclear factor-κB ligand. Denosumab is used in the treatment of postmenopausal osteoporosis and cancer-related bone disorders.
Stepan Kutilek
doaj